PFE - Cerevel appoints former ImmunoGen exec as CFO
2023-05-10 07:03:05 ET
- Cerevel Therapeutics ( NASDAQ: CERE ) appointed Susan Altschuller as CFO, effective May 15.
- Altschuller previously served as CFO of ImmunoGen ( IMGN ) and has also worked at Alexion, now a part of AstraZeneca.
- Mark Bodenrader had been serving as interim CFO of Cerevel.
- Earlier in May, Cerevel — which was spun out by Pfizer ( PFE ) — named Ron Renaud, a former partner of Bain Capital Life Sciences, as CEO, effective June 12. Pfizer and Bain Capital established CERE in 2018 when the pharma giant spun out its neuroscience division.
For further details see:
Cerevel appoints former ImmunoGen exec as CFO